Literature DB >> 1660298

Organ specificity of the antigens reacting with the 48-1 and S-1 antibodies in chimpanzees infected with hepatitis C virus.

M Sugitani1, Y K Shimizu, J Azumi, T Maeda, K Abe, T Shikata.   

Abstract

48-1 and S-1 antibodies produced by lymphoblastoid cells transformed with Epstein-Barr virus were reported to be associated with infection by not only the hepatitis non-A, non-B (NANB) virus but also hepatitis delta virus. Appearance of the antigens reacting with these antibodies in the liver of chimpanzees was recently found to be a host response to alpha-interferon induced by infections of both viruses. To investigate organ specificity of these antigens, various organs obtained from chimpanzees with hepatitis C (NANB) were examined. In addition to the liver, the adrenals and spleen were found to be positive by immunofluorescence. The positive reactions of these three organs were also confirmed by radioimmunoassay. By electron microscopy, microtubular aggregates similar to those observed in the liver were detected in the adrenals, but not in the spleen. The results suggested that these antigens existed in the liver, adrenal, and probably spleen of chimpanzees infected with hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660298      PMCID: PMC2002327     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  10 in total

1.  Induction of cylindrical confronting cisternae (AIDS inclusions) in Daudi lymphoblastoid cells by recombinant alpha-interferon.

Authors:  D Bockus; F Remington; J Y Luu; M Bean; S Hammar
Journal:  Hum Pathol       Date:  1988-01       Impact factor: 3.466

2.  Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non-A, non-B hepatitis in chimpanzees and their relation to D hepatitis.

Authors:  Y K Shimizu; R H Purcell; J L Gerin; S M Feinstone; Y Ono; T Shikata
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

3.  Transmission of non-A, non-B hepatitis agent to chimpanzees from patients of epidemic hepatitis.

Authors:  K Abe; T Shikata; K Fujisawa; M Yamauchi; H Matsushita; H Suzuki; T Oda
Journal:  Jpn J Med Sci Biol       Date:  1986-06

4.  Hepatic inclusions during interferon therapy in chronic viral hepatitis.

Authors:  Z Schaff; J H Hoofnagle; P M Grimley
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

5.  Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees.

Authors:  U Pfeifer; R Thomssen; K Legler; U Böttcher; W Gerlich; E Weinmann; O Klinge
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1980

6.  Cytoplasmic antigen in hepatocytes of chimpanzees infected with non-A, non-B hepatitis virus or hepatitis delta virus: relationship to interferon.

Authors:  Y K Shimizu; R H Purcell
Journal:  Hepatology       Date:  1989-11       Impact factor: 17.425

7.  Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus.

Authors:  Y K Shimizu; M Oomura; K Abe; M Uno; E Yamada; Y Ono; T Shikata
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Cloning, sequencing and expression in Escherichia coli of cDNA for a non-A, non-B hepatitis-associated microtubular aggregates protein.

Authors:  K Takahashi; N Kitamura; T Shibui; M Kamizono; R Matsui; Y Yoshiyama; T Maeda; J Kondo; Y Honda; E Yamada
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

9.  An epidemic of non-A, non-B hepatitis in Japan.

Authors:  M Yamauchi; H Nakajima; K Kimura; K Fujisawa; H Kameda; M Nakahara; Y Satoh; H Kawamura
Journal:  Am J Gastroenterol       Date:  1983-10       Impact factor: 10.864

10.  Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs.

Authors:  C Garzelli; F E Taub; J E Scharff; B S Prabhakar; F Ginsberg-Fellner; A L Notkins
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.